ASTH logo

Astrana Health, Inc. Stock Price

NasdaqCM:ASTH Community·US$2.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

ASTH Share Price Performance

US$49.17
25.02 (103.60%)
US$47.11
Fair Value
US$49.17
25.02 (103.60%)
36.6% overvalued intrinsic discount
US$36.00
Fair Value
Price US$49.17
AnalystConsensusTarget US$36.00
AnalystHighTarget US$50.00
AnalystLowTarget US$41.00

ASTH Community Narratives

·
Fair Value US$47.11 0.4% undervalued intrinsic discount

Value Based Care And Data Integration Will Advance US Healthcare

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
·
Fair Value US$50 6.2% undervalued intrinsic discount

Aging US Population And Medicare Advantage Will Transform Care Delivery

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$41 14.4% overvalued intrinsic discount

Policy And Integration Risks Will Hamper Prospects But Enable Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$41
14.4% overvalued intrinsic discount
Revenue
11.32% p.a.
Profit Margin
2.93%
Future PE
17.12x
Price in 2029
US$50.34
US$50
6.2% undervalued intrinsic discount
Revenue
11.23% p.a.
Profit Margin
3.54%
Future PE
17.35x
Price in 2029
US$61.38

Trending Discussion

Updated Narratives

ASTH logo

ASTH: Prospect Integration And Full-Risk Shift Will Test Value-Based Care Optimism

Fair Value: US$47.11 0.4% undervalued intrinsic discount
6 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ASTH logo

ASTH: Improved Care Outlook Will Test Prospect Integration And Multiple Expansion

Fair Value: US$41 14.4% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ASTH logo

ASTH: Prospect Integration And Full Risk Expansion Will Support Future Upside

Fair Value: US$50 6.2% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Moderate growth potential with low risk.

3 Risks
2 Rewards

Astrana Health, Inc. Key Details

US$3.5b

Revenue

US$3.2b

Cost of Revenue

US$375.9m

Gross Profit

US$345.7m

Other Expenses

US$30.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.61
10.66%
0.86%
178.0%
View Full Analysis

About ASTH

Founded
1992
Employees
3000
CEO
Brandon Sim
WebsiteView website
www.astranahealth.com

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Recent ASTH News & Updates

Narrative Update Jun 22

ASTH: Improved Care Outlook Will Test Prospect Integration And Multiple Expansion

Astrana Health's analyst price target has been raised from $26 to $41. Analysts point to an improved outlook for value based care, integration progress with Prospect and room for P/E multiple expansion as key supports for the higher valuation.
Analysis Article Jun 19

Astrana Health (ASTH) Stock Could Be 8.8% Overvalued After Strong Results

Astrana Health event: shelf registration follows strong operating performance Astrana Health (ASTH) recently filed a shelf registration for up to 1,000,000 common shares, tied to an ESOP related offering, shortly after reporting operating efficiency and financial metrics that highlight its current business momentum. See our latest analysis for Astrana Health. The latest shelf registration comes at a time when Astrana Health’s share price has gained 61.66% over the past 90 days and its 1 year...

Recent updates

No updates